Stephen Antonysamy

1.9k total citations
14 papers, 723 citations indexed

About

Stephen Antonysamy is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Stephen Antonysamy has authored 14 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Stephen Antonysamy's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (4 papers). Stephen Antonysamy is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (4 papers). Stephen Antonysamy collaborates with scholars based in United States, Canada and Singapore. Stephen Antonysamy's co-authors include Marijane Russell, Kenneth Weichert, Zhanna Druzina, Zahid Bonday, Robert M. Campbell, Aiping Zhang, T. Gheyi, Charles T. Rauch, Stephen R. Wasserman and J.M. Sauder and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Stephen Antonysamy

14 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Antonysamy United States	10	571	76	76	59	50	14	723
Jonathan Lippy United States	13	349 0.6×	124 1.6×	83 1.1×	90 1.5×	118 2.4×	25	505
Mahmoud N. Mansour United States	10	407 0.7×	130 1.7×	62 0.8×	74 1.3×	102 2.0×	11	798
Joseph E. Myers United States	10	283 0.5×	89 1.2×	59 0.8×	52 0.9×	94 1.9×	12	488
Jonathan L. Doty United States	8	315 0.6×	172 2.3×	78 1.0×	60 1.0×	43 0.9×	11	563
Malin Lemurell Sweden	12	402 0.7×	184 2.4×	49 0.6×	60 1.0×	48 1.0×	15	587
Lei Du‐Cuny United States	12	333 0.6×	85 1.1×	51 0.7×	32 0.5×	115 2.3×	14	467
Nurulhuda Mustafa Singapore	11	373 0.7×	100 1.3×	154 2.0×	33 0.6×	22 0.4×	22	594
Alfred A. Rabow United States	12	364 0.6×	73 1.0×	73 1.0×	39 0.7×	137 2.7×	14	502
Aras Emdadi United States	10	359 0.6×	139 1.8×	71 0.9×	24 0.4×	103 2.1×	10	479
John Strelow United States	7	247 0.4×	129 1.7×	65 0.9×	21 0.4×	84 1.7×	9	365

Countries citing papers authored by Stephen Antonysamy

Since Specialization

Citations

This map shows the geographic impact of Stephen Antonysamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Antonysamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Antonysamy more than expected).

Fields of papers citing papers by Stephen Antonysamy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Antonysamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Antonysamy. The network helps show where Stephen Antonysamy may publish in the future.

Co-authorship network of co-authors of Stephen Antonysamy

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Antonysamy. A scholar is included among the top collaborators of Stephen Antonysamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Antonysamy. Stephen Antonysamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Demarest, Stephen J., et al.. (2024). Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy. mAbs. 16(1). 2373325–2373325. 9 indexed citations

2.

Antonysamy, Stephen, Zhanna Druzina, Carolyn Y. Ho, et al.. (2020). Rapid and robust antibody Fab fragment crystallization utilizing edge-to-edge beta-sheet packing. PLoS ONE. 15(9). e0232311–e0232311. 14 indexed citations

3.

Ho, Joseph D., Matthew R. Lee, Charles T. Rauch, et al.. (2020). Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP). Biochimica et Biophysica Acta (BBA) - General Subjects. 1865(2). 129800–129800. 17 indexed citations

4.

Haidar, Jaafar N., Stephen Antonysamy, Sneha Mathew, et al.. (2019). Abstract 2753: The molecular basis of blocking the TIM-3 checkpoint with the LY3321367 mAb in cancer immunotherapy. Cancer Research. 79(13_Supplement). 2753–2753. 6 indexed citations

5.

Haidar, Jaafar N., Stephen Antonysamy, Sneha Mathew, et al.. (2019). Abstract 2753: The molecular basis of blocking the TIM-3 checkpoint with the LY3321367 mAb in cancer immunotherapy. 1 indexed citations

6.

Brooks, Nathan A., Lisa Kays, John Strelow, et al.. (2019). Abstract LB-274: Identification and characterization of LY3410738, a novel covalent inhibitor of cancer-associated mutant Isocitrate Dehydrogenase 1 (IDH1). Cancer Research. 79(13_Supplement). LB–274. 9 indexed citations

7.

Ting, Joey, Stephen Antonysamy, Stephen R. Wasserman, et al.. (2018). Utilization of peptide phage display to investigate hotspots on IL-17A and what it means for drug discovery. PLoS ONE. 13(1). e0190850–e0190850. 21 indexed citations

8.

Bonday, Zahid, Guillermo S. Cortez, Michael J. Grogan, et al.. (2018). LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity. ACS Medicinal Chemistry Letters. 9(7). 612–617. 119 indexed citations

9.

Antonysamy, Stephen. (2017). The Structure and Function of the PRMT5:MEP50 Complex. Sub-cellular biochemistry. 83. 185–194. 33 indexed citations

10.

Luz, J.G., Stephen Antonysamy, Bradley Condon, et al.. (2015). Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics. Journal of Medicinal Chemistry. 58(11). 4727–4737. 54 indexed citations

11.

Antonysamy, Stephen, Bradley Condon, Zhanna Druzina, et al.. (2013). Structural Context of Disease-Associated Mutations and Putative Mechanism of Autoinhibition Revealed by X-Ray Crystallographic Analysis of the EZH2-SET Domain. PLoS ONE. 8(12). e84147–e84147. 68 indexed citations

12.

Antonysamy, Stephen, Zahid Bonday, Robert M. Campbell, et al.. (2012). Crystal structure of the human PRMT5:MEP50 complex. Proceedings of the National Academy of Sciences. 109(44). 17960–17965. 256 indexed citations

13.

Antonysamy, Stephen, Gavin C. Hirst, Paul A. Sprengeler, et al.. (2008). Fragment-based discovery of JAK-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(1). 279–282. 64 indexed citations

14.

Antonysamy, Stephen, Brandon E. Aubol, Jeff Blaney, et al.. (2008). Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(9). 2990–2995. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact